In a report released yesterday, David Low from J.P. Morgan maintained a Buy rating on Resmed (RMD – Research Report), with a price target of $270.00. The company’s shares closed yesterday at ...
Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market ...
2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
ResMed Inc.’s RMD robust performance of its Mask business is supported by continued product development within the portfolio. Its Software-as-a-Service (SaaS) business continues to benefit from ...
What are the differences between cab types? A regular cab only has one row of seats and limited interior storage, while an extended cab has two rows of seats and also comes with small secondary ...
Please read this section before submitting anything to Nature. This section explains Nature's editorial criteria, and how manuscripts are handled by our editors between submission and acceptance ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈